Clinical Trial Update: A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of radiation therapy and cemiplimab for cutaneous squamous cell carcinoma, including locally advanced disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Libtayo (cemiplimab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cutaneous Squamous Cell Carcinoma, Skin Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING